RPCEC00000394Completed未知
Retrospective study of the administration of Jusvinza according to the CUBA action protocol, for the management of COVID-19 at the Hospital Dr. Luis Diaz Soto. (COVID-19) - VALENTIA
Center for Genetic Engineering and Biotechnology (CIGB)0 sites348 target enrollmentStarted: October 29, 2021Last updated:
Conditions
Trial Snapshot
- Phase
- 未知
- Status
- Completed
- Sponsor
- Enrollment
- 348
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Observational
Eligibility Criteria
- Ages
- 19 years to one (—)
- Sex
- All
Inclusion Criteria
- •1. Patients older than 19 years.
- •2. SARS-CoV-2 positive patients in moderate, severe or critical conditions, who have been indicated for treatment with Jusvinza, in the period between March 20 and September 6, 2021.
Exclusion Criteria
- •Not applicable
Investigators
Similar Trials
Not yet recruiting
Not Applicable
Proper use of Aharamatra (Diet) in relation to Agni (digestive capacity).CTRI/2019/07/020068ALL INDIA INSTITUTE OF AYURVEDA
Not yet recruiting
Phase 2
Jusvinza in Severe Patients with Acquired Community PneumoniaLung DiseasesRespiratory Tract DiseasesRespiratory Tract InfectionsPneumoniaSevere PneumoniaRPCEC00000411Center for Genetic Engineering and Biotechnology (CGIB), the Havana60
Completed
Phase 1
A clinical study to see the effect of Jeevaniya Ghrita Ashchyotana in management of Shushkakshipaka (computer vision syndrome).CTRI/2022/07/043769ational Institute of Ayurveda Jaipur30
Completed
Not Applicable
Clinical study to examine the effectiveness of Juzentaihoto in postoperative recovery for colorectal cancer patients - A research investigating the role of cell-mediated immunity in recoveryColorectal CancerJPRN-UMIN000001235Sapporo Medical University School of Medicine First Department of Surgery20
Not yet recruiting
Phase 3
Management of Acute Fissure by Yavadi Ghritam (locally) and Haritakichurna Vati (internally).CTRI/2024/07/069873Dr Abhinav Dubey